Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.
Fatima Iftikhar Shah, Somia Shehzadi, Fatima Akram, Ikram Ul Haq, Benish Javed, Sadeed Sabir, Yasha Kazim, Sehrish Ashfaq
Molecular biotechnology January 1, 2025 DOI: 10.1007/s12033-023-00994-7 via PubMed
Summary
AI-generated from the abstractPsilocybin, a natural hallucinogen found in certain mushrooms, shows potential therapeutic benefits for depression, a global health concern linked to suicide rates that is often difficult to treat with conventional drugs. Psilocybin alters mood, cognition, and perception by acting on serotonin receptors in the brain, and these shifts in consciousness may promote healing. This comprehensive review examines psilocybin's biosynthesis, mechanisms of action, therapeutic applications, and anti-depressive effects, aiming to advance psychiatric care and offer new hope for depression treatment.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Depression Psilocybin |
| Keywords | Disorder Mushroom Psilocybin therapy Mental health treatment Psychedelic medicine |
| Citations | 2 |
| Key finding | Psilocybin, a natural hallucinogen from certain mushrooms, may offer a novel approach to depression management by altering mood, cognition, and perception through action on serotonin receptors. |
Abstract
Depression, a global health concern with significant implications for suicide rates, remains challenging to treat effectively with conventional pharmacological options. The existing pharmaceutical interventions for these illnesses need daily dosing, are accompanied by various adverse effects, and may exhibit limited efficacy in certain cases. However, hope emerges from an unlikely source-Psilocybin, a natural hallucinogen found in certain mushrooms. Recently, this enigmatic compound has garnered attention for its potential therapeutic benefits in addressing various mental health issues, including depression. Psilocybin alters mood, cognition, and perception by acting on a particular subtype of serotonin receptors in the brain. It's feasible that these shifts in consciousness will promote healing development, offering a novel approach to depression management. This comprehensive review explores psilocybin, derived from specific mushrooms, and its implications in the treatment of depression. The study examines new perspectives and therapeutic possibilities surrounding psilocybin, addressing existing gaps in academic literature. It delves into its biosynthesis, unique mechanisms of action, therapeutic applications, and anti-depressive effects. By uncovering the potential of this mind-altering substance, the review aims to advance psychiatric care, offering hope to those globally affected by depression.